Email this article INFLUENCE OF CONCOMITANT ARTERIAL HYPERTENSION ON ACTIVITY OF INFLAMMATORY PROCESS IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
Abstract
The aim of the work was to determine the diagnostic value of the markers of surfactant protein D (SP-D) and C-reactive protein (C-RP) in patients with community-acquired pneumonia (CAP) with concomitant arterial hypertension (AH) and its effects on the activity of the inflammatory process.
The study included 79 people. Among them, 63 patients with CAP and 16 healthy individuals who were a control group. Depending on the presence of hypertension, the patients were divided into two groups. The first group included 26 patients with CAP with AH, the second – 37 patients with CAP without AH. All patients were given general-clinical methods of examination, radiography of the chest organs in two projections. Plasma levels of SP-D and C-RP were determined.
Reliable connection (p<0.05) was determined between the presence of AH and the probability of occurrence of CAP (OR - odds ratio 2.27 [95 % CI 1.05–4.94]). The level of SP-D and C-RP in patients with AH on the first day was significantly higher than in healthy subjects (p<0.05). In patients in the first group, SP-D levels were significantly higher (p<0.05) for the first, third and ninth day relative to the second group. The existence of a direct tie of average strength between the presence of AH and SP-D (R=0.41, p<0.05) has been determined. The presence of a direct correlation link of mean strength (R=0.38; p<0.05) between the AH and the level of C-RP indicates that arterial hypertension in patients with CAP increases the activity of the systemic inflammatory response.
Keywords
Full Text:
PDFReferences
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C. et. al. (2007). Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases, 44, 27–72. doi: 10.1086/511159
Corrales-Medina, V. F., Musher, D. M., Wells, G. A., Chirinos, J. A., Chen, L., Fine, M. J. (2012). Cardiac Complications in Patients With Community-Acquired Pneumonia: Incidence, Timing, Risk Factors, and Association With Short-Term Mortality. Circulation, 125 (6), 773–781. doi: 10.1161/circulationaha.111.040766
Dotsenko, N. Ya., Boev, S. S., Shekhunova, Y. A. et. al. (2015). Difficulties and frequent errors in the management of patients with arterial hypertension. Arterialnaya gipertenziya, 3 (41), 30–34.
Perry, T. W., Pugh, M. J. V., Waterer, G. W., Nakashima, B., Orihuela, C. J., Copeland, L. A. et. al. (2011). Incidence of Cardiovascular Events After Hospital Admission for Pneumonia. The American Journal of Medicine, 124 (3), 244–251. doi: 10.1016/j.amjmed.2010.11.014
Gargiulo, P., Banfi, C., Ghilardi, S., Magrì, D., Giovannardi, M., Bonomi, A. et. al. (2014). Surfactant-Derived Proteins as Markers of Alveolar Membrane Damage in Heart Failure. PLoS ONE, 9 (12), e115030. doi: 10.1371/journal.pone.0115030
Sin, D. D., Wu, L., Man, S. F. (2005). The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest, 127 (6), 1952–1959. doi: 10.1378/chest.127.6.1952
Atochina-Vasserman, E. N. (2012). S-nitrosylation of surfactant protein D as a modulator of pulmonary inflammation. Biochimica et Biophysica Acta (BBA) – General Subjects, 1820 (6), 763–769. doi: 10.1016/j.bbagen.2011.12.006
Atochina-Vasserman, E. N., Winkler, C., Abramova, H., Schaumann, F., Krug, N., Gow, A. J. et. al. (2011). Segmental Allergen Challenge Alters Multimeric Structure and Function of Surfactant Protein D in Humans. American Journal of Respiratory and Critical Care Medicine, 183 (7), 856–864. doi: 10.1164/rccm.201004-0654oc
Pertseva, T. O., Kireyeva, T. V., Shtepa O. O. (2015). The influence of comorbid pathology on expressiveness of inflammatory process in patients with lower respiratory tract infactions. Zaporozhye medical journal, 4 (91), 21–25. doi: 10.14739/2310-1210.2015.4.50306
Sorensen, G. L., Hjelmborg, J. V. B., Leth-Larsen, R., Schmidt, V., Fenger, M., Poulain, F. et. al. (2006). Surfactant Protein D of the Innate Immune Defence is Inversely Associated with Human Obesity and SP-D Deficiency Infers Increased Body Weight in Mice. Scandinavian Journal of Immunology, 64 (6), 633–638. doi: 10.1111/j.1365-3083.2006.01853.x
Schneider, J. P., Arkenau, M., Knudsen, L., Wedekind, D., Ochs, M. (2017). Lung remodeling in aging surfactant protein D deficient mice. Annals of Anatomy – Anatomischer Anzeiger, 211, 158–175. doi: 10.1016/j.aanat.2017.01.013
Hoegh, S. V., Sorensen, G. L., Tornoe, I., Lottenburger, T., Ytting, H., Nielsen, H. J. et. al. (2010). Long-term stability and circadian variation in circulating levels of surfactant protein D. Immunobiology, 215 (4), 314–320. doi: 10.1016/j.imbio.2009.05.001
Rebrova, O. Yu. (2002). Statistical analysis of medical data. The use of the application package statistics. Moscow: MediaSphere, 312.
Pertseva, T. O., Kireieva, T. V., Shtepa, O. O. (2014). Surfactant Protein D and C-Reactive Protein in patients with lower respiratory tract infections. The Pharma Innovation Journal, 3 (9), 27–31.
Hill, J., Heslop, C., Man, S. F. P., Frohlich, J., Connett, J. E., Anthonisen, N. R. et. al. (2011). Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality. European Heart Journal, 32 (15), 1918–1925. doi: 10.1093/eurheartj/ehr124
Pertseva, T. et. al. (2014). Surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with community acquired pneumonia (CAP) during the treatment program. European Respiratory Journal, 44 (58), 3645.
Pertseva, T. et al. (2014). The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patient (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP). European respiratory society, 3576.
Ware, L. B., Koyama, T., Billheimer, D. D., Wu, W., Bernard, G. R., Thompson, B. T. et. al. (2010). Prognostic and Pathogenetic Value of Combining Clinical and Biochemical Indices in Patients With Acute Lung Injury. Chest, 137 (2), 288–296. doi: 10.1378/chest.09-1484
Kalmatov, R. K., Zholdoshev, S. T., Karymova, N. A. (2015). Pathogenetic role of surfactant SP-D protein in diseases of the lungs and respiratory tract. Fundamentalnyie issledovaniya, 1, 1591–1595.
Sorensen, G. L. (2018). Surfactant Protein D in Respiratory and Non-Respiratory Diseases. Frontiers in Medicine, 5, 1–37. doi: 10.3389/fmed.2018.00018
Shtepa, O. A. (2015). Meaning of surfactant protein D as a marker of pathogenic microorganisms and the degree of damage of the lung tissue. Eksperementalna i klinichna medytsyna, 3 (68), 68–72.
Gaunsbaek, M. Q., Rasmussen, K. J., Beers, M. F., Atochina-Vasserman, E. N., Hansen, S. (2013). Lung Surfactant Protein D (SP-D) Response and Regulation During Acute and Chronic Lung Injury. Lung, 191 (3), 295–303. doi: 10.1007/s00408-013-9452-x
Hartl, D., Griese, M. (2006). Surfactant protein D in human lung diseases. European Journal of Clinical Investigation, 36 (6), 423–435. doi: 10.1111/j.1365-2362.2006.01648.x
Leth-Larsen, R., Nordenbaek, C., Tornoe, I., Moeller, V., Schlosser, A., Koch, C. et. al. (2003). Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia Clinical Immunology, 108 (1), 29–37. doi: 10.1016/s1521-6616(03)00042-1
Mandal, P., Chalmers, J. D., Choudhury, G., Akram, A. R., Hill, A. T. (2011). Vascular complications are associated with poor outcome in community-acquired pneumonia. QJM, 104 (6), 489–495. doi: 10.1093/qjmed/hcq247
DOI: http://dx.doi.org/10.21303/2504-5679.2018.00614
Refbacks
- There are currently no refbacks.
Copyright (c) 2018 Olha Shtepa
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)